The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Mutations in TERT, the Gene for Telomerase Reverse Transcriptase, in Aplastic Anemia
Open accessAbstract
BACKGROUND: Mutations in TERC, the gene for the RNA component of telomerase, cause short telomeres in congenital aplastic anemia and in some cases of apparently acquired hematopoietic failure. We investigated whether mutations in genes for other components of telomerase also occur in aplastic anemia. METHODS: We screened blood or marrow cells from 124 patients with apparently acquired aplastic anemia and 282 control subjects for sequence variations in the TERT, DKC1, NHP2, and NOP10 genes; an additional 81 patients and 246 controls were examined for genetic variations in TERT. Telomere lengths and the telomerase activity of peripheral-blood leukocytes were evaluated in patients carrying genetic variants. Identified mutations were transfected into telomerase-deficient cell lines to examine their effects and their mechanism of action on telomerase function. RESULTS: Five heterozygous, nonsynonymous mutations (which cause an amino acid change in the corresponding protein) were identified in TERT, the gene for the telomerase reverse transcriptase catalytic enzyme, among seven unrelated patients. Leukocytes from these patients had short telomeres and low telomerase enzymatic activity. In three of these patients, the mutation was also detected in buccal mucosa cells. Family members carrying the mutations also had short telomeres and reduced telomerase activity but no evident hematologic abnormality. The results of coexpression of wild-type TERT and TERT with aplastic anemia-associated mutations in a telomerase-deficient cell line suggested that haploinsufficiency was the mechanism of telomere shortening due to TERT mutations. CONCLUSIONS: Heterozygous mutations in the TERT gene impair telomerase activity by haploinsufficiency and may be risk factors for marrow failure.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“Insufficient telomerase activity, stemming from low telomerase reverse transcriptase (TERT) gene transcription, contributes to telomere dysfunction and aging pathologies.”
From TERT activation targets DNA methylation and multiple aging hallmarks (2024) · cites this paper as [10]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Patients with shorter telomeres at diagnosis show a more severe disease, a poorer response to treatments, an increased risk of relapse and development of myelodysplastic syndrome (MDS; see below) and a lower survival rate75,80,81.”
From Telomere dysfunction in ageing and age-related diseases (2022) · cites this paper as [75]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Around 9% of patients with acquired aplastic anaemia carry mutations in the telomerase components TERC, TERT and DKC1, which are also mutated in inherited aplastic anaemia, as in dyskeratosis congenita74,75.”
From Telomere dysfunction in ageing and age-related diseases (2022) · cites this paper as [75]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“About one-third of patients with aplastic anaemia show short telomeres in peripheral blood, which suggests that there is a causative link between aplastic anaemia pathology and telomere dysfunction75,76,79.”
From Telomere dysfunction in ageing and age-related diseases (2022) · cites this paper as [75]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Indeed, defects in telomerase activity due to germ-line mutations in core telomerase components are linked to the premature loss of tissue renewal and premature death, such as dyskeratosis congenita,9 aplastic anemia10 and idiopathic pulmonary fibrosis.11”
From TERT activation targets DNA methylation and multiple aging hallmarks (2024) · cites this paper as [10]
Experimental — accuracy not yet measured
In the citing paper
“They manifest in an autosomal-dominant inheritance pattern because complete or partial loss-of-function of one allele is sufficient to perturb telomere maintenance38,39,41.”
From The telomere syndromes (2012) · cites this paper as [41]
In the citing paper
“In addition, 3–5% of aplastic anaemia patients carry mutant TERT and TR genes41,72,73.”
From The telomere syndromes (2012) · cites this paper as [41]
In the citing paper
“In both humans and mice, there is clear evidence that short telomeres cause quantitative and qualitative defects in HSCs, which manifest as stem cell exhaustion36,41,71,114–117 (Fig. 4).”
From The telomere syndromes (2012) · cites this paper as [41]
In the citing paper
“None of the seven mutations were found in 94 locally collected, ethnically matched individuals, nor were they detected in 200 patients with aplastic anemia or a multiethnic panel of 528 individuals sequenced as controls (9).”
From Adult-onset pulmonary fibrosis caused by mutations in telomerase (2007) · cites this paper as [9]
In the citing paper
“The individuals with TERT or TERC mutations have none of the physical manifestations of DKC and were all ascertained by the lung fibrosis phenotype, distinguishing them from previously described patients with mutations in these genes (6, 9, 10, 17).”
From Adult-onset pulmonary fibrosis caused by mutations in telomerase (2007) · cites this paper as [9]
In the citing paper
“By contrast, telomere shortening is accelerated in several human premature ageing syndromes, and patients with dyskeratosis congenita and aplastic anaemia show decreased telomerase activity and shortened telomeres owing to mutations in the TERC and TERT telomerase genes.”
From The common biology of cancer and ageing (2007) · cites this paper as [61]
In the citing paper
“patients who have inherited or acquired genetic defects that limit telomere maintenance seem to be at substantially increased risk of a range of conditions including aplastic anaemia 61 , idiopathic pulmonary fibrosis 62, 63 and the rarer dyskeratosis congenita syndrome”
From The common biology of cancer and ageing (2007) · cites this paper as [61]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Telomerase Catalytic Subunit Homologs from Fission Yeast and Human
Nakamura, T. M., Morin, G. B., Chapman, K. B., Weinrich, S. L., Andrews, W. H., Lingner, J., Harley, C. B., & Cech, T. R. (1997) · Science · doi:10.1126/science.277.5328.955 · Cited by 2,256
Switching and Signaling at the Telomere
Blackburn, E. H. (2001) · Cell · doi:10.1016/s0092-8674(01)00492-5 · Cited by 2,139
Telomere Shortening and Tumor Formation by Mouse Cells Lacking Telomerase RNA
Blasco, M. A., Lee, H.-W., Hande, M. P., Samper, E., Lansdorp, P. M., DePinho, R. A., & Greider, C. W. (1997) · Cell · doi:10.1016/s0092-8674(01)80006-4 · Cited by 2,108
Self-citationOlovnikov (1973) · doi:10.1016/0022-5193(73)90198-7 · Cited by 1,847
Longevity, Stress Response, and Cancer in Aging Telomerase-Deficient Mice
Rudolph, K. L., Chang, S., Lee, H.-W., Blasco, M., Gottlieb, G. J., Greider, C., & DePinho, R. A. (1999) · Cell · doi:10.1016/s0092-8674(00)80580-2 · Cited by 1,349
Essential role of mouse telomerase in highly proliferative organs
Lee, H.-W., Blasco, M. A., Gottlieb, G. J., Horner, J. W., Greider, C. W., & DePinho, R. A. (1998) · Nature · doi:10.1038/33345 · Cited by 1,270
Reverse Transcriptase Motifs in the Catalytic Subunit of Telomerase
Lingner, J., Hughes, T. R., Shevchenko, A., Mann, M., Lundblad, V., & Cech, T. R. (1997) · Science · doi:10.1126/science.276.5312.561 · Cited by 1,269
A telomerase component is defective in the human disease dyskeratosis congenita
Mitchell, J. R., Wood, E., & Collins, K. (1999) · Nature · doi:10.1038/990141 · Cited by 1,168
Heiss, N. S., Knight, S. W., Vulliamy, T. J., Klauck, S. M., Wiemann, S., Mason, P. J., Poustka, A., & Dokal, I. (1998) · Nature Genetics · doi:10.1038/ng0598-32 · Cited by 976
The RNA component of telomerase is mutated in autosomal dominant dyskeratosis congenita
Vulliamy, T., Marrone, A., Goldman, F., Dearlove, A., Bessler, M., Mason, P. J., & Dokal, I. (2001) · Nature · doi:10.1038/35096585 · Cited by 960
Flagged first, then by citations
Research works printed but not linked: 1
- Alter BP. Inherited bone marrow failure syndromes: introduction. In: Young NS, Alter BP, eds. Aplastic anemia, acquired and inherited. Philadelphia: W.B. Saunders, 1994:271-4.
Cited by
Sorted by citations
Items 501–600 of 725
Telomerase as a Target for Cancer Therapeutics
Shay, J. W. (2010) · Springer eBooks · doi:10.1007/978-1-4419-6102-0_13 · Cited by 8
NOLA1 gene mutations in acquired aplastic anemia
Pigullo, S., Pavesi, E., Dianzani, I., Santamaria, G., Svahn, J., Risso, M., Lint, M. T. V., Pillon, M., Iori, A. P., Longoni, D. V., et al. (2008) · Pediatric Blood & Cancer · doi:10.1002/pbc.21813 · Cited by 8
Bulduk, T. (2023) · Medicine · doi:10.1097/md.0000000000034862 · Cited by 9
Multidisciplinary approaches to study anaemia with special mention on aplastic anaemia (Review)
Sankar, D., & Oviya, I. (2024) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2024.5419 · Cited by 7
Doss, C. G. P., Chakraborty, C., Rajith, B., & Nagasundaram, N. (2013) · Journal of Molecular Modeling · doi:10.1007/s00894-013-1888-7 · Cited by 7
Robey, P. G., & Riminucci, M. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814841-9.00002-6 · Cited by 7
TERT and TERC mutations detected in cryptic dyskeratosis congenita suppress telomerase activity
Terada, K., Miyake, K., Yamaguchi, H., Miyake, N., Yamanaka, K., Kojima, S., Ito, E., Inokuchi, K., & Okada, T. (2020) · International Journal of Laboratory Hematology · doi:10.1111/ijlh.13176 · Cited by 8
Self-citationMutational analysis of telomere complex genes in Indian population with acquired aplastic anemia
Singh, I., Nunia, V., Sharma, R., Barupal, J. K., Govindaraj, P., Jain, R., Gupta, G. N., & Goyal, P. K. (2015) · Leukemia Research · doi:10.1016/j.leukres.2015.08.018 · Cited by 7
Alpha Blockers and Metabolic Syndrome.
Mehta, S., Krishnamohan, M., Gulati, S., Sharmat, N., Vashishtha, P., & Singh, I. (2014) · PubMed · Cited by 7
Ayas, M. F., & Ahmed, S. O. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804152-9.00018-x · Cited by 7
Dyskeratosis congenita: a disorder of telomerase deficiency and its relationship to other diseases
Marrone, A., & Dokal, I. S. (2006) · Expert Review of Dermatology · doi:10.1586/17469872.1.3.463 · Cited by 7
Telomerase Mutations in Aplastic Anemia
Fibbe, W. E. (2005) · New England Journal of Medicine · doi:10.1056/nejme058015 · Cited by 7
Childhood Trauma in Depressive Disorders
Aas, M., & Étain, B. (2020) · Springer eBooks · doi:10.1007/978-3-030-49414-8_9 · Cited by 7
Man, T., Aubert, G., Richard, M. A., LeJeune, W., Hariri, E., Goltsova, T., Gaikwad, A., Chen, Y., Whitton, J., Leisenring, W. M., et al. (2021) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-21-0791 · Cited by 6
O'Connor, T. E., Shaw, R. C., Madero‐Marroquin, R., & Roloff, G. W. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1180439 · Cited by 6
El‐Badry, M., Espinoza, J. L., & Nakao, S. (2017) · Experimental Hematology · doi:10.1016/j.exphem.2016.12.011 · Cited by 6
Germ line predisposition to myeloid malignancies appearing in adulthood
Crysandt, M. M., Brings, K., Beier, F., Thiede, C., Brümmendorf, T. H., & Jost, E. (2018) · Expert Review of Hematology · doi:10.1080/17474086.2018.1494566 · Cited by 7
Dokal, I. S. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-405546-9.00011-x · Cited by 6
Finke, J., Bertz, H., Kaskel, A.-K., Heinz, J., Thomas, A. K., Berger, D. P., Engelhardt, R., & Schmah, O. (2008) · Springer eBooks · doi:10.1007/978-3-540-73277-8_6 · Cited by 6
Marsh, J. C. W., & Young, N. S. (2010) · doi:10.1002/9781444323160.ch13 · Cited by 6
Self-citationMalleability of Short Telomeres by Telomerase Activators: A Mini-review
Paolisso, V. B. G. (2013) · Journal of Aging Science · doi:10.4172/2329-8847.1000108 · Cited by 5
Telomeres and Telomerase Activity in the Human Placenta
Jirkovská, M., Korabečná, M., & Laššáková, S. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.86327 · Cited by 5
Çepni, E., Satkın, N. B., Moheb, L. A., Rocha, M. E., & Kayserili, H. (2021) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.62602 · Cited by 5
Targeting Telomerase in Hematologic Malignancy
Maritz, M. F., Napier, C. E., Wen, V. W., & MacKenzie, K. L. (2010) · Future Oncology · doi:10.2217/fon.10.42 · Cited by 5
Syndromes Associated with Telomere Shortening
Nag, S. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.88792 · Cited by 4
Immunosuppressive therapy for transplant-ineligible aplastic anemia patients
Schrezenmeier, H., Körper, S., & Höchsmann, B. (2015) · Expert Review of Hematology · doi:10.1586/17474086.2015.978759 · Cited by 5
Wilcox, M. E., Rivera, M. P., Sassoon, C. S. H., Ware, L. B., Wunsch, H., & Herridge, M. S. (2012) · Proceedings of the American Thoracic Society · doi:10.1513/pats.201206-033tt · Cited by 5
Inherited Aplastic Anaemia/Bone Marrow Failure Syndromes
Dokal, I. S. (2015) · Wiley eBooks · doi:10.1002/9781118853771.ch10 · Cited by 5
Environment and sex control lifespan and telomere length in wild-derived African killifishPreprint
Reichard, M., Giannetti, K., Ferreira, T., Vrtílek, M., Polačik, M., Blažek, R., & Ferreira, M. G. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.09.03.280792 · Cited by 5
Elbadry, M. I., Tawfeek, A., Hirano, T., El‐Mokhtar, M. A., Kenawey, M., Helmy, A. M., Ogawa, S., Zulf Mughal, M., & Nannya, Y. (2023) · British Journal of Haematology · doi:10.1111/bjh.19176 · Cited by 4
Comparison of telomere length in patients with bone marrow failure syndromes and healthy controls
Barade, A., Lakshmi, K. M., Korula, A., Abubacker, F. N., Kulkarni, U. P., Abraham, A., Mathews, V., George, B., & Edison, E. S. (2024) · European Journal Of Haematology · doi:10.1111/ejh.14173 · Cited by 4
Sugino, S., Bortz, B., Vaida, S. J., Karamchandani, K., & Janicki, P. K. (2015) · A & A Case Reports · doi:10.1213/xaa.0000000000000198 · Cited by 4
Telomere Maintenance and Genome Stability
Hernandez-Sanchez, W. M., Xu, M., & Taylor, D. J. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-803309-8.00021-5 · Cited by 4
Oxidative Telomere Attrition, Nutritional Antioxidants and Biological Aging
Glade, M. J. (2015) · International Journal Of Nutrition · doi:10.14302/issn.2379-7835.ijn-14-606 · Cited by 3
Barabino, S. M. L., Citterio, E., & Ronchi, A. E. (2021) · Cancers · doi:10.3390/cancers13153753 · Cited by 4
Introduction to Telomeres and Telomerase
Songyang, Z. (2017) · Methods in molecular biology · doi:10.1007/978-1-4939-6892-3_1 · Cited by 4
TERC haploid cell reprogramming: a novel therapeutic strategy for aplastic anemia
Tang, X. T., Xu, R., Wang, Y., Chen, K., & Cui, S. (2023) · Molecular Medicine · doi:10.1186/s10020-023-00691-w · Cited by 4
Current management of severe acquired aplastic anemia
Scheinberg, P. (2011) · Einstein (São Paulo) · doi:10.1590/s1679-45082011rw2156 · Cited by 4
Regulation of cell fate by near infrared-responsive telomerase activity
Wang, J., Shi, P., Dong, K., Yan, Z., Ren, J., & Qu, X. (2017) · Materials Today · doi:10.1016/j.mattod.2017.07.004 · Cited by 4
Telomeres and Telomerase in Humans
Hiyama, K., Hiyama, E., & Shay, J. W. (2009) · Humana Press eBooks · doi:10.1007/978-1-60327-879-9_1 · Cited by 4
Dynamics and plasticity of chromosome ends: consequences in human pathologies
Schluth‐Bolard, C., Ottaviani, A., Bah, A., Boussouar, A., Gilson, É., & Magdinier, F. (2011) · Atlas of Genetics and Cytogenetics in Oncology and Haematology · doi:10.4267/2042/44767 · Cited by 5
Dyskeratosis Congenita Complicated by Hepatic Fibrosis With Hepatic Vein Thrombosis
Yoshida, H., Imamura, T., Sakamoto, K., Asai, D., Nakatani, T., Morimoto, A., & Hosoi, H. (2013) · Journal of Pediatric Hematology/Oncology · doi:10.1097/mph.0000000000000001 · Cited by 4
Benson, K. F., & Horwitz, M. S. (2006) · Best Practice & Research Clinical Haematology · doi:10.1016/j.beha.2005.11.002 · Cited by 5
Hematopoietic Cell Transplantation for Aplastic Anemia
Georges, G. E., & Storb, R. F. (2015) · doi:10.1002/9781118416426.ch46 · Cited by 4
Inherited Aplastic Anaemia/Bone Marrow Failure Syndromes
Dokal, I. S. (2010) · Wiley eBooks · doi:10.1002/9781444323160.ch12 · Cited by 4
Ji, Y., Gong, J., Sedlazeck, F. J., & Fan, S. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.08.03.502734 · Cited by 5
Borges, G. D. O., Benslimane, Y., & Harrington, L. A. (2024) · Biogerontology · doi:10.1007/s10522-024-10094-x · Cited by 3
Klinaki, E., & Ogrodnik, M. B. (2024) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2024.111929 · Cited by 3
Clinics and genetics of hyperhemolysis syndrome in patients with sickle cell disease
Malta, B., Ozahata, M. C., Moura, I. C. G., Amorim, L., Ferraz, A., Belisário, A. R., Miranda, C., Kelly, S., Custer, B., Sabino, É. C., et al. (2025) · Transfusion · doi:10.1111/trf.18232 · Cited by 3
Zhuang, X., Liao, L., Guo, Y., Li, Y., Liao, X.-X., Hu, X., & Du, Z.-M. (2015) · International Journal of Cardiology · doi:10.1016/j.ijcard.2015.02.032 · Cited by 3
Mutation of SBDS and SH2D1A is not associated with aplastic anemia in Japanese children
Wang, Y., Yagasaki, H., Hama, A., Nishio, N., Takahashi, Y., & Kojima, S. (2007) · Haematologica · doi:10.3324/haematol.11568 · Cited by 3
Mohanty, P., Jadhav, P., Shanmukhaiah, C., Kumar, S., & Vundinti, B. R. (2019) · International Journal of Dermatology · doi:10.1111/ijd.14424 · Cited by 3
The approximate formulas predicting personal somatic telomere length using patient blood test data
Maeda, T., Horiuchi, T., & Makino, N. (2019) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2019-0262 · Cited by 3
Continuous reference intervals for leukocyte telomere length in children: the method matters
Lesmana, A., Tian, P., Karlaftis, V., Hearps, S. J. C., Monagle, P., Ignjatović, V., & Elwood, N. J. (2021) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2021-0059 · Cited by 3
Guérin, C., Crestani, B., Dupin, C., Kawano-Dourado, L. B., Ba, I., Kannengiesser, C., & Borie, R. (2022) · Revue des Maladies Respiratoires · doi:10.1016/j.rmr.2022.03.011 · Cited by 4
Xu, J., de Oliveira, D. M., Trudeau, M. A., Yang, Y., Chin, J. J. Y., Sin, D. D., Sandford, A. J., & Wong, J. M. Y. (2021) · Scientific Reports · doi:10.1038/s41598-021-83686-z · Cited by 3
Variations in exon‐2 of SBDS gene and its association with aplastic anemia
Jain, D., Malik, A. A., KUMAR, A. T., Malik, B. K., & Raina, V. (2014) · International Journal of Laboratory Hematology · doi:10.1111/ijlh.12202 · Cited by 3
Hartwig, F. P. (2013) · Journal of Stem Cell Research & Therapy · doi:10.4172/2157-7633.s3-003 · Cited by 3
Maiti, S. N. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-3684-7_5 · Cited by 3
Garcia, C. K. (2012) · Proceedings of the American Thoracic Society · Cited by 3
[Advances in the pathogenesis of aplastic anaemia].
Yang, J. R., Wang, H., & Shao, Z. (2019) · PubMed Central · doi:10.3760/cma.j.issn.0253-2727.2019.09.022 · Cited by 3
Teo, J., & Dror, Y. (2006) · doi:10.1002/9780470987001.ch4 · Cited by 3
Ji, Y., Zhao, J., Gong, J., Sedlazeck, F. J., & Fan, S. (2024) · Molecular Genetics and Genomics · doi:10.1007/s00438-024-02158-x · Cited by 8
Carlier, F. M., Planté-Bordeneuve, T., Froidure, A., Graux, C., van Dievoet, M., van Moorsel, C. H. M., & Hoffman, T. W. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1718107 · Cited by 2
Samuelov, L., Sarig, O., Goldsmith, T., Pavlovsky, M., Goldberg, I., Sagie, S., Selig, S., & Sprecher, E. (2015) · Clinical and Experimental Dermatology · doi:10.1111/ced.12599 · Cited by 2
Hypoplastic form of myelodysplastic neoplasm
Votavová, H., Lenertová, Z., Votava, T., & Beličková, M. (2023) · Klinicka onkologie · doi:10.48095/ccko2023206 · Cited by 2
Genetic Counseling and Family Screening Recommendations in Patients with Telomere Biology Disorders
Ongie, L. J., Raj, H. A., & Stevens, K. B. (2023) · Current Hematologic Malignancy Reports · doi:10.1007/s11899-023-00713-8 · Cited by 2
Fernández-Varas, B., Manguán-García, C., Rodríguez-Centeno, J., Mendoza-Lupiáñez, L., Calatayud, J., Perona, R., Martín‐Martinez, M., Gutiérrez‐Rodríguez, M., Benitéz‐Buelga, C., & Sastre, L. (2024) · Human Molecular Genetics · doi:10.1093/hmg/ddae015 · Cited by 3
Novel telomerase reverse transcriptase gene mutation in a family with aplastic anaemia
Virijević, M., Marjanović, I., Andjelkovic, M., Jakovic, L. R., Micic, D., Bogdanovic, A. D., & Pavlović, S. (2024) · Familial Cancer · doi:10.1007/s10689-024-00399-8 · Cited by 2
Genomic analysis reveals population structure and selection signatures in plateau dairy cattle
Huang, S., Ma, L., Li, B., Dou, J., Xu, Q., & Wang, Y. (2025) · BMC Genomics · doi:10.1186/s12864-025-11335-0 · Cited by 2
The impact of clonal hematopoiesis on outcomes in patients with aplastic anemia
Brzeźniakiewicz‐Janus, K., Rupa‐Matysek, J., Hoppe, A., & Gil, L. (2021) · Acta Haematologica Polonica · doi:10.5603/ahp.a2021.0026 · Cited by 2
Telomerase Mutations and Premature Ageing in Humans
Du, H., Bessler, M., & Mason, P. J. (2007) · Springer eBooks · doi:10.1007/978-3-540-73709-4_5 · Cited by 2
Myelodysplastic Syndrome in Children
Niemeyer, C. M. (2013) · Springer eBooks · doi:10.1007/978-3-642-36229-3_14 · Cited by 2
Duc, H. T. (2014) · Biomedicine & Aging Pathology · doi:10.1016/j.biomag.2014.03.006 · Cited by 2
Discovery and Characterization of Cancer Genetic Susceptibility Alleles
Chanock, S. J., & Ostrander, E. A. (2014) · Elsevier eBooks · doi:10.1016/b978-1-4557-2865-7.00022-9 · Cited by 2
Self-citationSchmidt, S. L., & Flaherty, K. R. (2011) · Proceedings of the American Thoracic Society · doi:10.1513/pats.201108-045tt · Cited by 2
An update on Acquired Aplastic Anemia
Solomou, E. E. (2017) · Hematology & Transfusion International Journal · doi:10.15406/htij.2017.04.00080 · Cited by 2
Structural modeling of a novel TERC variant in a patient with aplastic anemia and short telomeres
Rinelli, M., Bellacchio, E., Berardinelli, F., Pascolini, G., Grammatico, P., Sgura, A., Iori, A. P., Quattrocchi, L., Novelli, A., Majore, S., et al. (2018) · Annals of Hematology · doi:10.1007/s00277-018-3415-5 · Cited by 2
Acquired aplastic anemia and Fanconi anemia
Gupta, V. K., & Marsh, J. C. W. (2009) · Elsevier eBooks · doi:10.1016/b978-0-443-10147-2.50020-5 · Cited by 2
Genetic Interstitial Lung Disease
Garcia, C. K. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-48024-6.00001-x · Cited by 3
Socié, G., Xhaard, A., Robin, M., & de Latour, R. P. (2013) · Encyclopédie médico-chirurgicale. Hématologie · doi:10.1016/s1155-1984(12)60051-x · Cited by 2
Gutierrez, L. G., & Ju, Z. (2007) · Springer eBooks · doi:10.1007/978-3-540-73709-4_8 · Cited by 2
Socié, G., Ferry, C., Robin, M., & Mary, J. Y. (2005) · Encyclopédie médico-chirurgicale. Hématologie · doi:10.1016/j.emch.2005.01.002 · Cited by 2
Telomere Binding Proteins and Disease
Blasco, M. A. (2007) · Springer eBooks · doi:10.1007/978-3-540-73709-4_12 · Cited by 2
Genetics of Pulmonary Fibrosis
Adams, T. N., & Garcia, C. K. (2018) · Respiratory medicine · doi:10.1007/978-3-319-99975-3_8 · Cited by 2
Babushok, D. V., Hsu, A. P., & Dokal, I. S. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-816768-7.00016-8 · Cited by 2
TERT Structure, Function, and Molecular Mechanisms
Skordalakes, E., & Lue, N. F. (2012) · Wiley eBooks · doi:10.1002/9781118268667.ch3 · Cited by 2
Genetic predisposition to myeloproliferative neoplasms implicates hematopoietic stem cell biologyPreprint
Bao, E. L., Nandakumar, S. K., Liao, X., Bick, A. G., Karjalainen, J. M., Tabaka, M., Gan, O. I., Havulinna, A. S., Kiiskinen, T., Lareau, C. A., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/790626 · Cited by 2
Irvine, A. D., & Mellerio, J. E. (2016) · Wiley eBooks · doi:10.1002/9781118441213.rtd0078 · Cited by 2
Sánchez-Vazquez, R., García-Oteyza, S. B., Serrano, R., Flores, J. M., Martínez, P., & Blasco, M. A. (2025) · Genes & Development · doi:10.1101/gad.352855.125 · Cited by 2
Dyskeratosis congenita as a multifaceted bone marrow disorder
Mazurek, M., Madzio, J., & Mlynarski, W. M. (2023) · Acta Haematologica Polonica · doi:10.5603/ahp.95640 · Cited by 2
Genetic variants associated with white blood cell count amongst individuals with sickle cell disease
Ozahata, M. C., Guo, Y., Gomes, I. C., Malta, B., Belisário, A. R., Amorim, L., Teles, D., Flor‐Park, M. V., Kelly, S., Sabino, É. C., et al. (2024) · British Journal of Haematology · doi:10.1111/bjh.19758 · Cited by 1
Tata, P., Ghosh, A., Trinath, J., Kulkarni, O. P., Ganesan, R., & Dutta, J. R. (2025) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.4c01424 · Cited by 1
Gao, Z., Yu, Y., Wiggins, D., Sevick-Muraca, E. M., & Kolonin, M. G. (2026) · Aging Cell · doi:10.1111/acel.70490 · Cited by 1
Schratz, K. E., & Armanios, M. Y. (2026) · NEJM Evidence · doi:10.1056/evidra2600012 · Cited by 1
Genetic Predispositions for Hematologic and Lymphoid Disorders
Behm, F. G. (2010) · Molecular pathology library · doi:10.1007/978-1-4419-5698-9_2 · Cited by 1
Carulli, L., Anzivino, C., Bertolotti, M., Loria, P., Richeldi, L., & Cerri, S. (2014) · Case Reports in Internal Medicine · doi:10.5430/crim.v2n1p11 · Cited by 1
Telomere Biology in T Cells: An Important Brake on the Road of Their Life Span?
Röth, A., & Baerlocher, G. M. (2009) · Clinical Leukemia · doi:10.3816/clk.2009.n.005 · Cited by 1
Self-citationA sequence-dependent exonuclease activity from Tetrahymena thermophila
Tom, H.-I., & Greider, C. W. (2010) · BMC Biochemistry · doi:10.1186/1471-2091-11-45 · Cited by 1
Forensic Application of Telomere Shortening in Age-at-Death Estimation
Adserias‐Garriga, J. (2017) · CRC Press eBooks · doi:10.1201/9781315371382-19 · Cited by 1
Metadata
- Authors
- Yamaguchi, H., Calado, R. T., Ly, H., Kajigaya, S., Baerlocher, G. M., Chanock, S. J., Lansdorp, P. M., & Young, N. S.
- Affiliations
- National Institutes of Health (US)
- National Heart, Lung, and Blood Institute (US)
- Emory University (US)
- Terry Fox Research Institute (CA)
- University of British Columbia (CA)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2005-04-07
- Volume
- 352
- Issue
- 14
- Pages
- 1413-1424
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2037236933
- Cited by
- 723
- References
- 52
- Citations by year
- 2026: 14 · 2025: 12 · 2024: 27 · 2023: 23 · 2022: 26 · 2021: 21 · 2020: 27 · 2019: 28 · 2018: 28 · 2017: 39 · 2016: 23 · 2015: 37 · 2014: 49 · 2013: 44 · 2012: 32
- FWCI
- 30.18
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Health Sciences › Medicine › Hematology › Blood disorders and treatments
- Health Sciences › Medicine › Hematology › Acute Myeloid Leukemia Research
- Keywords
- TERT mutation, telomerase reverse transcriptase, aplastic anemia, telomere shortening, haploinsufficiency, telomerase activity, DKC1, NHP2, NOP10, hematopoietic failure, non-synonymous mutations, leukocytes
- MeSH terms
- Adult, Aged, Anemia, Aplastic, Bone Marrow Cells, DNA Mutational Analysis, DNA-Binding Proteins, Female, Heterozygote, Humans, Male, Middle Aged, Mutation, Risk Factors, RNA, Gene Expression, Case-Control Studies, Polymerase Chain Reaction, Telomere, Telomerase
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
